Atypical amelogenesis: xử lý lâm sàng

Amelogenesis Imperfecta: A Comprehensive Monograph on Molecular Etiology, Clinical Management, and Patient-Centric Outcomes

I. Clinical Synopsis

Amelogenesis Imperfecta (AI) represents a complex, clinically and genetically heterogeneous group of rare hereditary disorders characterized by defective enamel formation, affecting both the primary (deciduous) and permanent dentitions.1 This condition is the direct result of mutations in one of several genes responsible for the intricate biological process of amelogenesis (enamel formation), leading to what is fundamentally an "enamel protein malfunction".1 The clinical manifestations are severe and highly variable, including gross tooth discoloration (ranging from opaque, chalky white to yellow-brown), profound structural failure (pitting, grooving, rapid and severe wear, and catastrophic breakage), and extreme dental hypersensitivity to thermal and osmotic stimuli.1 Crucially, Amelogenesis Imperfecta must not be misinterpreted as a purely aesthetic or cosmetic concern. It is a profound functional and psychosocial disability. The constellation of pain, poor aesthetics, and masticatory dysfunction is strongly associated with a markedly decreased Oral Health-Related Quality of Life (OHRQoL), which in turn can lead to social avoidance, anxiety, and significant patient and family distress.10 Management is complex, non-elective, and lifelong. It demands an early and accurate diagnosis, a meticulously phased treatment plan that adapts to the patient's dental development, and a coordinated multidisciplinary team of pediatric dentists, prosthodontists, orthodontists, and oral-maxillofacial surgeons.1 This monograph provides an exhaustive review of Amelogenesis Imperfecta, from its molecular underpinnings and genetic architecture to the evidence-based clinical protocols required to restore function, aesthetics, and quality of life for affected individuals.

II. The Biological Basis of Enamel and its Defects

Understanding Amelogenesis: A Biphasic Process

The foundation of Amelogenesis Imperfecta pathophysiology lies in the disruption of amelogenesis, the highly orchestrated and complex biological process of enamel formation executed by specialized epithelial cells known as ameloblasts.17 This process is divided into two critical and sequential stages: 1. The Secretory (Formative) Phase: During this initial stage, ameloblasts deposit an intricate, protein-rich organic matrix. This matrix is primarily composed of proteins such as amelogenin and enamelin, which serve as a scaffold.8 The secretory phase is responsible for establishing the full thickness and overall shape of the future enamel crown.17 2. The Maturation (Mineralization) Phase: Following the secretory phase, the process shifts to maturation. This stage involves the systematic enzymatic breakdown and removal of the protein-rich matrix. This degradation is mediated by proteases, most notably Matrix Metallopeptidase 20 (MMP20) and Kallikrein 4 (KLK4).5 The removal of this protein scaffold allows for the massive influx of calcium and phosphate ions, which then grow into the large, tightly packed, and highly organized hydroxyapatite crystals that give mature enamel its characteristic hardness and translucency.8

Pathophysiology of Defective Enamel: Quantitative vs. Qualitative Defects

The clinical classification of Amelogenesis Imperfecta is not arbitrary; it is a direct physical record of a failure in one of these two distinct biological phases. The specific AI phenotype is the macroscopic expression of a microscopic, stage-specific disruption.

• Quantitative Defects (Hypoplasia): A genetic mutation or environmental insult that disrupts ameloblast function during the secretory phase impairs the cells' ability to deposit the organic matrix. The result is enamel that is insufficient in quantity—it is abnormally thin.1 While thin, this enamel may be properly mineralized during the subsequent maturation phase and can therefore be relatively hard and translucent.1 This manifests clinically as Type I (Hypoplastic) AI.
• Qualitative Defects (Hypomaturation & Hypocalcification): A mutation that disrupts the maturation phase results in a different defect. The secretory phase proceeds normally, laying down a matrix of full thickness. However, the subsequent mineralization process fails. This is often due to a failure in the protease cascade (e.g., in MMP20 or KLK4 mutations) or mineral transport.5 The protein matrix is not effectively removed and is retained within the final structure, preventing the full growth of hydroxyapatite crystals. The result is enamel that is of normal thickness but is deficient in quality—it is soft, porous, opaque, and poorly mineralized.1 This manifests clinically as Type II (Hypomaturation) and Type III (Hypocalcified) AI.

This biological understanding is the cornerstone of diagnosis. A clinician observing thin-but-hard, pitted enamel (Hypoplastic AI) can definitively conclude that the genetic fault affected secretory-phase proteins or processes. Conversely, a clinician seeing soft, chalky, or "cheese-like" enamel of normal thickness (Hypocalcified AI) knows the fault lies within the maturation-phase cascade.

III. Classification, Epidemiology, and Clinical Presentation

A Clinical Typology of Amelogenesis Imperfecta

While research has described at least 14 different forms of AI 7, the most clinically useful classification system divides the condition into four main types based on the clinical phenotype and the underlying developmental defect 1: 1. Type I: Hypoplastic: This type is the classic quantitative defect. The enamel is hard and can be translucent but is abnormally thin, failing to achieve its normal thickness. The surface texture is variable, appearing either smooth and glossy or, more commonly, marked by pits, horizontal grooves, or large areas of missing enamel.1 2. Type II: Hypomaturation: This is a qualitative defect. The enamel is secreted to its normal, full thickness but fails to mature properly. It is therefore soft, mottled (lốm đốm), and has an opaque, "chalky" white appearance.1 A specific presentation known as "snow-capped" AI, where the opaque defect is limited to the incisal or occlusal third of the crown, falls into this category.23 Because the enamel is soft, it is highly prone to chipping and fracturing away from the underlying, healthy dentin.1 3. Type III: Hypocalcified: This is the most severe qualitative defect. The enamel is of normal thickness but is exceptionally soft, porous, and friable, described in clinical literature as having a "cheese-like" (giống như "phô mai") consistency.1 It offers minimal functional protection and is often lost rapidly or abraded away almost immediately after the teeth erupt into the oral cavity, leaving the sensitive dentin core exposed.1 4. Type IV: Hypomaturation-Hypoplastic with Taurodontism: This type is a mixed phenotype, exhibiting features of both quantitative (hypoplastic) and qualitative (hypomaturation) defects. Its defining characteristic is that it is always associated with the radiographic finding of taurodontism—a dental anomaly where the tooth body and pulp chamber are enlarged, and the furcation is apically displaced.1

Epidemiology and Prevalence

The reported prevalence of Amelogenesis Imperfecta varies dramatically in the scientific literature, a fact that has significant implications for its genetic basis. Published estimates range widely, from 1 in 14,000 people in the United States to as high as 1 in 700 in some populations in northern Sweden.3 This 20-fold variance is too large to be explained by reporting discrepancies or diagnostic criteria alone. The most plausible explanation is the influence of genetic founder effects. Many forms of AI, particularly those resulting from mutations in protease genes like MMP20 and KLK4, are transmitted as autosomal recessive traits.28 Such conditions are statistically far more common in populations with a limited or historically isolated gene pool. Therefore, the high 1:700 prevalence reported in "northern Sweden" 22 is almost certainly due to a specific founder mutation becoming concentrated in that population over generations. This suggests that AI prevalence is not uniform globally but is rather a collection of demographic "hotspots" driven by distinct events in population genetics.

Core Clinical Hallmarks and Patient Presentation

Regardless of the specific genetic type, patients with AI present with a constellation of severe, debilitating clinical problems stemming directly from the defective enamel 1:

• Discoloration: The teeth are aesthetically compromised, appearing either yellow-brown (as the dark, underlying dentin shows through the thin or porous, "see-through" enamel) or as an opaque, chalky-white.1
• Hypersensitivity: This is a primary patient complaint. The thin or porous enamel fails to act as an effective insulating barrier for the dentin and pulp. This leads to severe, often debilitating, pain and sensitivity to thermal (hot and cold) and osmotic (sweet) stimuli.1
• Structural Failure: The weak, friable, or thin enamel is mechanically incompetent. It is prone to rapid and severe occlusal wear (mòn), chipping, and catastrophic fracture (gãy vỡ) under normal masticatory forces.1
• Loss of Occlusal Vertical Dimension (VDO): The rapid and progressive wear of the posterior teeth leads to a "mất kích thước dọc của khớp cắn" (loss of vertical dimension of occlusion).1 This causes a collapsed bite, which in turn leads to significant difficulties in chewing, potential temporomandibular joint (TMJ) dysfunction, and adverse aesthetic changes to the lower third of the face.
• Associated Dental Anomalies: The genetic disruption of amelogenesis is often accompanied by other dental problems. AI patients have a notably high incidence of anterior open bite, skeletal malocclusions, impaction of permanent teeth, and secondary periodontal (gum) disease.15

IV. The Genetic Architecture of Amelogenesis Imperfecta

Amelogenesis Imperfecta is a classic monogenic disorder, meaning it is caused by a mutation in a single gene.31 It can follow X-linked, autosomal dominant, or autosomal recessive inheritance patterns.2 While mutations in at least 18 genes have been implicated in AI 20, a few key genes are responsible for the majority of non-syndromic cases, and their specific mechanisms of failure are now well-understood.7

FAM83H: The Dominant-Negative Driver of Hypocalcified AI

• Gene and Inheritance: Mutations in the FAM83H gene cause Autosomal Dominant Hypocalcified AI (ADHCAI).33 This is one of the most common genetic etiologies for AI.7
• Phenotype: This mutation produces the classic Type III Hypocalcified phenotype. The enamel is extremely soft, yellow-brown, rough, and is rapidly lost after eruption.29 It is very frequently associated with skeletal malocclusions, particularly anterior open bite and Class III malocclusion.29
• Pathogenic Mechanism: The mechanism of FAM83H mutations is a critical distinction. The causative mutations are typically nonsense or frameshift mutations that create an abnormally short, truncated protein.33 This abnormal protein mislocalizes, moving from the cytoplasm (its normal location) into the cell's nucleus.37 Crucially, mouse models where the Fam83h gene is completely knocked out (a true loss-of-function) show no enamel defects.33 However, mouse models engineered to express the truncation mutation (replicating the human disease) exhibit severe AI.39 This definitively proves that the disease is not caused by an absence of the normal FAM83H protein (a mechanism known as haploinsufficiency). Instead, it is caused by the toxic presence of the abnormal, truncated protein, which actively interferes with ameloblast function. This is a "neomorphic" or "dominant-negative" gain-of-function, identifying the abnormal protein itself as the pathogenic agent.33

AMELX: X-Linked AI and Phenotypic Variance

• Gene and Inheritance: Mutations in the AMELX (Amelogenin) gene, located on the X-chromosome, cause X-linked AI.7
• Phenotype: The clinical presentation is classically sex-specific. Affected males (hemizygous, with one X chromosome) show a severe, generalized phenotype. Heterozygous females (with two X chromosomes) exhibit a milder, often "mottled" or "vertically-grooved" appearance. This unique female phenotype is the result of lyonization—the random inactivation of one X chromosome in each ameloblast cell lineage, creating a mosaic of healthy and defective enamel.7
• Genotype-Phenotype Correlation: A clear genotype-phenotype correlation exists for AMELX mutations based on the location of the mutation on the protein. Evidence shows that mutations altering the C-terminus (the 3' end) of the amelogenin protein consistently result in a hypoplastic (quantitative) phenotype.41 In contrast, other AMELX mutations (e.g., in the N-terminus or signal peptide) tend to cause hypomaturation (qualitative) defects.41 This distinction is clinically vital, as it allows for phenotypic prediction from a genetic test, which in turn has major implications for treatment planning. The "snow-capped" teeth phenotype (Type IIC) is a specific hypomaturation AI linked to AMELX mutations.23

ENAM: The Dose-Dependent Gene

• Gene and Inheritance: Mutations in the ENAM (Enamelin) gene are a well-established cause of autosomal-dominant AI.6
• Pathogenic Mechanism: ENAM mutations demonstrate a clear "gene dosage" effect, a phenomenon that can result in two distinct clinical diagnoses arising from the very same mutation within a family. Multiple studies have shown that individuals who are homozygous for a specific ENAM mutation (i.e., they inherited two defective copies) present with severe, generalized, thin hypoplastic AI.43 However, their relatives (such as parents) who are heterozygous for the exact same mutation (i.e., they have one defective copy and one normal copy) present with a much milder, dominant trait: "localised hypoplastic enamel pitting".43 This finding is clinically profound. A patient presenting with "localized enamel pits" might easily be misdiagnosed with a non-hereditary, environmental defect. However, genetic testing and a thorough family history are crucial, as this heterozygous carrier, while only mildly affected, has a 25% chance (if their partner is also a carrier) of having a child with severe generalized AI. This knowledge fundamentally changes the diagnostic and genetic counseling approach for localized enamel defects.

MMP20 & KLK4: The Protease Failure Genes

• Gene and Inheritance: Mutations in MMP20 (Enamelysin) and KLK4 (Kallikrein 4) are transmitted as autosomal recessive traits.28
• Mechanism: These genes encode the essential proteases that orchestrate the maturation phase. MMP20 is the early-stage protease that cleaves matrix proteins during secretion, while KLK4 is the late-stage protease responsible for the final degradation and removal of the matrix to allow for mineralization.5 Inactivating mutations in either gene cause a failure of this degradation process.5
• Phenotype: The retained protein matrix and failed mineralization result in a classic Type II Hypomaturation phenotype. The enamel is of normal thickness but is soft, poorly mineralized, and often has a characteristic pigmented, "orange-brown" coloration.28

Table 1: Genetic Etiology and Genotype-Phenotype Correlation in Non-Syndromic AI

Gene Protein/Function Inheritance Pattern AI Type & Clinical Phenotype Key Pathogenic Feature/Insight FAM83H Unknown; scaffolding? 33 Autosomal Dominant 33 Type III: Hypocalcified 34

Severe, soft, "cheese-like," yellow-brown enamel. Rapid post-eruptive loss. Often assoc. with anterior open bite.29 Neomorphic (Toxic Gain-of-Function) 39

Truncated, mislocalized protein is actively pathogenic, not a loss-of-function.33 AMELX Amelogenin (Primary matrix protein) 20 X-Linked 7 Mixed: Hypoplastic or Hypomaturation 42

Males: Severe, generalized defects.

Females: Milder, vertically-grooved/mottled (Lyonization).24 Genotype-Phenotype Correlation

C-terminus (3') mutations $\rightarrow$ Hypoplastic (thin).41

Other mutations $\rightarrow$ Hypomaturation (soft).42 ENAM Enamelin (Matrix protein) 6 Autosomal Dominant 6 Type I: Hypoplastic 43

Homozygous: Severe, generalized thin enamel.44

Heterozygous: Localized horizontal pitting.43 Gene-Dosage Effect 44

The same mutation causes two distinct diagnoses (severe AI vs. localized pits) based on gene dose (homozygous vs. heterozygous). MMP20 Matrix Metallopeptidase 20 (Early Protease) 5 Autosomal Recessive 28 Type II: Hypomaturation 28

Normal thickness, soft, pigmented (orange-brown) enamel.48 Retained protein matrix. Protease Failure (Early Maturation) 5

Inability to degrade protein matrix during secretion/early maturation. KLK4 Kallikrein 4 (Late Protease) 5 Autosomal Recessive 28 Type II: Hypomaturation 28

Normal thickness, soft, pigmented enamel. Retained protein matrix.47 Protease Failure (Late Maturation) 5

Inability to remove protein matrix during final maturation.

V. Differential Diagnosis and Syndromic Associations

A definitive diagnosis of Amelogenesis Imperfecta requires two crucial steps: first, differentiating it from more common, non-hereditary environmental enamel defects, and second, identifying if the AI is an isolated dental trait or a manifestation of a larger, systemic syndrome.4

Distinguishing Hereditary AI from Environmental Enamel Hypoplasia

While both AI and environmental defects can present as "hypoplasia" (thin, pitted enamel), their etiology and clinical presentation are distinct.

• Etiology and Distribution: AI is a hereditary disorder that causes severe, widespread defects affecting all teeth in both the primary and permanent dentitions in a more-or-less equal manner.2 Environmental enamel hypoplasia is an acquired defect caused by a discrete systemic or local insult that occurs during the "window of vulnerability" of tooth formation (from infancy to approximately eight years of age).17
• Clinical Presentation: Because environmental defects are time-specific, they are typically "chronological," affecting only the parts of the teeth that were actively forming at the time of the insult, often appearing as horizontal bands or rows of pits.17 Or, they may be localized to a single tooth.17
• Common Environmental Causes: A thorough medical history is key to identifying these insults 17:
• Prenatal/Perinatal Factors: Maternal health issues such as gestational diabetes, infections, smoking, or significant nutritional deficiencies (especially Vitamin D).17 Complications at birth, such as premature birth and low birth weight, are strongly associated with enamel hypoplasia.17
• Systemic Illness (Postnatal): High fevers associated with common childhood infections (e.g., measles, chickenpox), chronic conditions such as celiac disease, liver disease, or kidney disease, and nutritional deficiencies (Vitamins A, C, and D) during critical growth periods.17
• Local Trauma: A physical injury (e.g., a fall) or infection affecting a primary (baby) tooth can damage the underlying developing permanent tooth bud. This results in a localized area of hypoplasia on that single tooth, an anomaly known as a "Turner's Tooth".17

The chronology of human tooth development is well-established and predictable. This allows an environmental hypoplastic defect to serve as a permanent, indelible biomarker of when a significant systemic health event occurred.17 A defect near the incisal edge of a permanent central incisor indicates a metabolic or physiological stressor in the child's first year of life, while a defect closer to the gumline points to an event around age four or five.17 This transforms the dental diagnosis into a powerful tool for pediatric and public health. An astute dental clinician can "read" the teeth and inform a pediatrician that the child suffered a major systemic insult at a specific, identifiable age, potentially unmasking an undiagnosed condition like celiac disease, for which the enamel defect may be the first or only presenting sign.17

Differentiating AI from Dental Fluorosis

Dental fluorosis is a specific developmental disturbance of enamel that is often confused with AI, but it is not AI.23

• Etiology: AI is genetic.1 Dental fluorosis is a specific qualitative (hypomineralization) defect caused by the chronic ingestion of excessive fluoride during amelogenesis.8
• Presentation: Fluorosis typically presents as diffuse, bilateral, "lacy" or "paper white" opacities with indistinct borders.17 AI, in contrast, presents as discrete pits, grooves, or generalized softness and discoloration.1 While the "snow-capped" phenotype can be seen in both, the underlying etiology is distinct.23

Amelogenesis Imperfecta as a Systemic Indicator (Syndromic AI)

The identification of AI should immediately trigger a systemic review and consideration of a medical referral. The enamel defect may be the first and most obvious feature of a severe, life-altering, or life-threatening underlying syndrome.

1. Jalili Syndrome (AI and Cone-Rod Dystrophy)

• Presentation: This syndrome is characterized by the devastating combination of Amelogenesis Imperfecta with progressive, severe vision loss.51 The ocular symptoms include cone-rod retinal dystrophy (CORD), severe photophobia (light sensitivity), nystagmus (involuntary eye movements), and eventual progression to blindness.51
• Genetics: Jalili syndrome is an autosomal recessive disorder caused by mutations in the CNNM4 gene, which is believed to be involved in metal ion transport.52
• Dental Phenotype: The AI component is typically a severe hypomineralized or hypoplastic type, with teeth appearing yellow-brown, dysplastic, and prone to failure.51

2. Enamel-Renal Syndrome (AI and Nephrocalcinosis)

• Presentation: This extremely rare syndrome is defined by the association of hypoplastic AI with nephrocalcinosis, which is the precipitation of calcium salts within the kidney tissue.56
• Dental Phenotype: The AI is typically a severe hypoplastic type. It is commonly associated with other specific dental anomalies, including delayed tooth eruption, multiple unerupted permanent teeth, and intrapulpal calcifications (calcifications within the tooth's nerve space).57
• Systemic Risk: The nephrocalcinosis is often silent and asymptomatic in childhood. However, it is a progressive condition that can lead to impaired renal function, recurrent urinary infections, and, in some cases, progression to end-stage renal failure.58

The existence of these syndromes represents a profound shift in clinical responsibility for the dental practitioner. The dentist may be the first or only healthcare provider in a position to identify the condition. Based on case reports of Enamel-Renal Syndrome, it has been advocated that children presenting with an apparent autosomal recessive hypoplastic AI, especially if associated with unerupted teeth, should receive a renal ultrasound examination to screen for nephrocalcinosis.59 Failure to recognize this association and initiate a medical referral is a missed opportunity to diagnose a silent but progressive renal disease and prevent irreversible kidney failure.58 Likewise, a dentist who notes severe photophobia in a child with AI 51 may be the key provider who initiates the ophthalmologic referral that leads to a diagnosis of Jalili Syndrome.

VI. The Human Context: Psychosocial Burden and Quality of Life

A critical, and historically overlooked, dimension of Amelogenesis Imperfecta is its severe, non-cosmetic impact on the patient's life. The condition is far more than an aesthetic issue; it is a significant functional and psychosocial disability.

Beyond Aesthetics: The Functional and Psychosocial Disability

The clinical hallmarks of AI—chronic pain from hypersensitivity, poor aesthetics, and functional impairment in chewing—combine to create a significant psychosocial burden for affected individuals and their families.

• A systematic review of Patient-Reported Outcome Measures (PROMs) in AI patients synthesized the patient experience into seven key domains of negative impact: Oral Health-Related Quality of Life (OHRQoL), Dental Fear, Esthetics, Psychosocial Factors, Function, Dental Hypersensitivity, and Treatment Outcome.13
• Comparative studies confirm this burden. Individuals with AI demonstrate significantly higher levels of social avoidance and distress when compared to unaffected controls.10 They also consistently report a markedly poorer OHRQoL.12
• Patients and parents report severe embarrassment, social self-consciousness, difficulties in social interaction, functional challenges with eating, and pain from hypersensitivity.11 This chronic pain experience can also lead to heightened dental anxiety, as normally innocuous stimuli like air or water from a dental handpiece can be intensely painful.65
• The burden extends to the entire family. Parents report high levels of psychosocial stress related to managing the child's care, feelings of guilt over the hereditary nature of the disorder, and significant frustration with dental and medical professionals who may be unfamiliar with the condition and its management.66

The primary barrier to care for many AI patients is the high cost of the full-mouth rehabilitation, a treatment that third-party payers (insurance) have traditionally denied as being "solely for esthetic reasons".10 The extensive body of psychosocial and quality-of-life research provides the direct and necessary counter-argument. This treatment is not elective or cosmetic; it is a medically necessary intervention to restore function and remediate a diagnosed disability. This is not a subjective claim; it is a quantifiable outcome. Studies measuring QoL before and after treatment provide definitive proof. One study found that "After crown therapy, quality of life problems… decreased significantly".68 Another study quantified this improvement, showing that patient happiness with their teeth jumped from a baseline of 33% (pre-treatment) and 41% (mid-treatment) to 81% (post-treatment).69 This body of evidence 10 is the clinician's most powerful tool for patient advocacy. It must be used to draft letters of medical necessity to payers, reframing full-mouth prosthetic rehabilitation not as an aesthetic upgrade, but as an essential medical treatment for a diagnosed functional and psychosocial disorder.

VII. A Phased Framework for Lifelong Clinical Management

Treatment for Amelogenesis Imperfecta is not a single event but a lifelong process that must be meticulously phased according to the patient's chronological age and dental development.1 The primary goals of this phased management are: 1. To protect the existing, vulnerable tooth structure from wear, fracture, and dental caries.1 2. To manage and eliminate dental hypersensitivity.1 3. To restore normal masticatory function and aesthetics.1 4. To establish and maintain the occlusal vertical dimension (VDO).1

Phase I: Pediatric and Mixed Dentition Management (Early Intervention)

This initial phase begins as soon as the teeth erupt and is focused on protection, prevention, and maintenance of space and VDO. It aims to stabilize the dentition until the patient is old enough for definitive restorations.1

• Posterior Teeth: The standard of care for primary molars and, critically, for newly erupted permanent molars is the immediate placement of Stainless Steel Crowns (SSCs).1 This intervention is non-negotiable for protecting the soft, vulnerable molars from the catastrophic occlusal wear that would otherwise occur, thereby preserving the VDO and preventing a collapsed bite.1
• Anterior Teeth: Restoration of the anterior teeth is typically achieved with pre-fabricated composite (strip) crowns or direct composite fillings/veneers.1 These serve as essential transitional restorations to improve aesthetics, reduce debilitating sensitivity, and protect the incisal edges from fracture.

Phase II: Adolescent and Permanent Dentition Management (Definitive Rehabilitation)

This is the definitive phase of treatment, which typically begins after all permanent teeth have erupted (excluding third molars) and skeletal growth is nearing completion.1 It involves a comprehensive, full-mouth rehabilitation.

• Definitive Restorations: The "dứt điểm" (definitive solution) and the preferred treatment of choice for providing long-term, predictable protection is the Full-Coverage Crown (Mão toàn diện).1 Crowns encircle the tooth, providing maximum mechanical protection against fracture, restoring the correct VDO, and offering optimal, long-term functional and aesthetic results.
• Material Choice: Modern all-ceramic materials are highly preferred for their combination of strength and aesthetics. Specifically, lithium disilicate (e.max) is noted for its excellent track record of durability and aesthetics in AI patients.1 Full-coverage zirconia crowns are also an excellent and durable option, particularly for high-stress posterior areas.74
• Veneers (Mặt dán sứ): The use of porcelain veneers is a limited and case-selective option. Veneers are only a viable treatment modality in less severe hypoplastic (Type I) cases.1 This is because they are an adhesive-reliant restoration and require sufficient, healthy, and bondable enamel structure to achieve a reliable and durable bond. They are explicitly contraindicated in hypocalcified and severe hypomaturation types, where the underlying enamel substrate is too soft and friable to support an adhesive bond.

VIII. The Multidisciplinary Team: An Integrated Approach

The complexity of AI, which often involves not just the teeth but the entire craniofacial complex, mandates a coordinated, multidisciplinary team approach for successful, long-term outcomes.14

• The Restorative/Prosthodontic Lead: This specialist (often a prosthodontist or a pediatric dentist with advanced restorative training) typically quarterbacks the overall treatment plan. They are responsible for managing the VDO, sequencing the treatment, and designing and delivering the final, full-mouth prosthetic rehabilitation.15
• The Orthodontic Role: Orthodontic intervention is frequently a prerequisite for the final restorative phase.1 There is a high prevalence of skeletal and dental malocclusions in AI patients, particularly anterior open bite and Class III jaw relationships.1 Orthodontic treatment is necessary to correctly align the teeth and arches before definitive restorations are placed.1 This presents its own clinical challenge, as bonding orthodontic brackets to defective enamel can be difficult and require specialized protocols.76
• The Oral-Maxillofacial Surgery Role: In cases with a severe underlying skeletal discrepancy (where the jaw bones themselves are misaligned), prosthetic and orthodontic treatment alone is insufficient. Orthognathic surgery (corrective jaw surgery), such as a LeFort I osteotomy or genioplasty, is required to correct the jaw relationships. This surgery establishes a stable, functional, and aesthetic skeletal foundation upon which the final prosthodontic rehabilitation can be built.15
• The Pediatric and Periodontal Role: The pediatric dentist is essential for executing the critical Phase I interventions, managing the patient's dental development, and coordinating the transition to adult care.73 The periodontist ensures a foundation of gingival (gum) health, as the long-term success of full-coverage crowns is highly dependent on healthy tissues and properly designed crown margins that permit effective oral hygiene.16

IX. Long-Term Prognosis and Clinical Challenges

While modern dentistry can achieve excellent functional and aesthetic outcomes, the long-term prognosis for AI patients is fraught with challenges. Management is a lifelong commitment that condemns the patient to a "restorative cycle" 71 and requires a deep understanding of the unique clinical challenges posed by defective enamel.

Restoration Longevity: The Primary Challenge

The primary challenge in AI management is the significantly reduced longevity of dental restorations compared to those placed in healthy teeth.77 The defective enamel substrate is the weak link. One study powerfully illustrates this: the 5-year survival rate for composite resin restorations in AI patients was found to be only ~50%, compared to 80% in non-AI controls.77 This high failure rate necessitates frequent replacements, consuming clinical resources and adding to the patient's lifelong treatment burden.

The Adhesive Dentistry Conundrum

The fundamental reason for this high restorative failure rate is the profound challenge of adhesive dentistry—bonding to the defective enamel.1 The long-term prognosis of any restoration is therefore directly dependent on the AI phenotype, which in turn is dependent on the underlying genotype. The clinical evidence is clear: "Patients with hypomineralized/hypomaturized AI have restorations of shorter longevity than those with hypoplastic AI".78 The biological reason for this is that in hypocalcified and hypomaturation types, the enamel is soft, porous, and rich in retained protein.79 It offers "insufficient enamel for bonding," and the bond fails not at the adhesive interface, but because the substrate itself fractures.79 Conversely, in hypoplastic (Type I) AI, the enamel is thin but it is hard and well-mineralized.1 Adhesive techniques can be reliable on this compromised but competent substrate.80 This connection is the central principle of modern AI management. It links the entire diagnostic and treatment pathway:

• A patient with a FAM83H mutation (Genotype) will have Type III Hypocalcified enamel (Phenotype). This substrate is non-bondable, giving an extremely poor prognosis for adhesive dentistry (veneers, composites). The treatment plan must therefore be based on full-coverage crowns, which rely on mechanical retention.
• A patient with a heterozygous ENAM mutation (Genotype) will have localized hypoplastic pits (Phenotype). This substrate is hard and bondable, giving a good prognosis for adhesive dentistry. The treatment plan can therefore utilize more conservative veneers or composite restorations.

This demonstrates that a molecular (genetic) diagnosis is not merely an academic exercise; it is an essential prerequisite for accurate treatment planning and prognostication.

The Definitive Solution Prognosis

Despite the extremely poor prognosis for adhesive restorations in qualitative AI types, the prognosis for the definitive solution—full-coverage crowns—is excellent. In stark contrast to the 50% failure rate of composites, long-term studies on modern ceramic crowns (lithium disilicate and zirconia) in AI patients report a survival rate of 99.6% after 5 years.77 This success rate, which is similar to that in non-AI patients, confirms that full-coverage restoration is the most predictable, durable, and definitive treatment for stabilizing the dentition and restoring quality of life for individuals with severe Amelogenesis Imperfecta.77

X. Future Directions and Concluding Analysis

Amelogenesis Imperfecta is a complex and debilitating molecular disorder of enamel formation, not a superficial cosmetic dental problem. Its impact on patient function, comfort, and psychosocial health is severe, well-documented, and lifelong, making its comprehensive treatment a medical and functional necessity. This analysis has demonstrated that: 1. AI is not a single disease. It is a heterogeneous group of disorders. The specific genotype (e.g., FAM83H, AMELX, ENAM, MMP20, KLK4) dictates the specific molecular protein failure (e.g., a neomorphic toxic protein, a loss-of-function, or a protease failure). 2. The molecular failure dictates the clinical phenotype. This determines whether the final enamel defect is quantitative (Hypoplastic—thin but hard) or qualitative (Hypocalcified/Hypomaturation—normal thickness but soft). 3. The clinical phenotype dictates the treatment and prognosis. Hypoplastic AI, with its competent enamel substrate, may be managed with adhesive restorations. Hypocalcified AI, with its friable and non-bondable substrate, requires full-coverage crowns for any predictable, long-term success. 4. The dentist is a key systemic diagnostician. The identification of AI, particularly in its autosomal recessive forms, must trigger a systemic review and appropriate medical referrals to rule out serious, silent syndromic conditions like Enamel-Renal Syndrome (requiring a renal ultrasound referral) 60 and Jalili Syndrome (requiring an ophthalmologic referral).51 The future of Amelogenesis Imperfecta management lies in the integration of molecular diagnostics into the initial treatment plan. The routine use of genetic testing can provide an early, definitive diagnosis, allowing the multidisciplinary clinical team to anticipate the specific disease trajectory and severity, accurately counsel the family, screen for life-altering systemic syndromes, and—most importantly—select the correct restorative protocol from the outset. This "genotype-to-phenotype-to-treatment" approach is the key to breaking the "restorative cycle" and definitively improving the long-term prognosis and quality of life for these patients. Nguồn trích dẫn 1. Bất Thường Hình Thái Răng: Chẩn Đoán, Xử Trí, https://drive.google.com/open?id=1sRfKXnzJ8lgAsaxZPVw8tTNcV0v4C4EWI3FIlAzoALE 2. Amelogenesis Imperfecta: A Case Series from the Community – PMC – PubMed Central, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8827610/ 3. Amelogenesis imperfecta – PMC – PubMed Central, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC1853073/ 4. Amelogenesis imperfecta: Next-generation sequencing sheds light on Witkop's classification – Frontiers, truy cập vào tháng 11 13, 2025, https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2023.1130175/full 5. Amelogenesis Imperfecta; Genes, Proteins, and Pathways – PMC – PubMed Central, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC5483479/ 6. Amelogenesis Imperfecta: Types, Symptoms & Treatment – Cleveland Clinic, truy cập vào tháng 11 13, 2025, https://my.clevelandclinic.org/health/diseases/amelogenesis-imperfecta 7. Amelogenesis imperfecta – Genetics – MedlinePlus, truy cập vào tháng 11 13, 2025, https://medlineplus.gov/genetics/condition/amelogenesis-imperfecta/ 8. 2017_@dentoflix_Tina_Raked_Orthodontics.pdf, https://drive.google.com/open?id=1TRFy52kb0nX_7AtC-6gNr9QWCwX9SrOx 9. 2017_@dentoflix_Tina_Raked_Orthodontics.pdf, https://drive.google.com/open?id=1Qh2FmphuqkF97QCUIWBILkaeB-8_oLLm 10. The psychosocial impact of developmental dental defects in people with hereditary amelogenesis imperfecta – PubMed, truy cập vào tháng 11 13, 2025, https://pubmed.ncbi.nlm.nih.gov/15966649/ 11. The psychosocial impact of developmental dental defects in people with hereditary Amelogenesis Imperfecta | Request PDF – ResearchGate, truy cập vào tháng 11 13, 2025, https://www.researchgate.net/publication/7776085_The_psychosocial_impact_of_developmental_dental_defects_in_people_with_hereditary_Amelogenesis_Imperfecta 12. Impact of moderate and severe hypodontia and amelogenesis imperfecta on quality of life and self-esteem of adult patients – PubMed, truy cập vào tháng 11 13, 2025, https://pubmed.ncbi.nlm.nih.gov/23778130/ 13. Patient-reported outcome measures in individuals with amelogenesis imperfecta: a systematic review – PMC – NIH, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9750902/ 14. Multidisciplinary Management of a Child with Severe Open Bite and Amelogenesis Imperfecta, truy cập vào tháng 11 13, 2025, https://www.thejcdp.com/doi/10.5005/jp-journals-10024-1321 15. Surgical, orthodontic, and prosthetic management of amelogenesis imperfecta associated with severe open bite: a case report, truy cập vào tháng 11 13, 2025, https://medandlife.org/wp-content/uploads/JMedLife-17-956.pdf 16. Multidisciplinary Management of Amelogenesis Imperfecta in an Adolescent, truy cập vào tháng 11 13, 2025, https://decisionsindentistry.com/article/multidisciplinary-management-of-amelogenesis-imperfecta-in-an-adolescent/ 17. Tooth Spots: Fluorosis vs. Hypoplasia, https://drive.google.com/open?id=1CU00GLugiGErtFr1d0n_B7rtSn8nulsqCLwQTM-45ek 18. Tooth Spots: Fluorosis vs. Hypoplasia, https://drive.google.com/open?id=19I6rqG0kCLQaTF-iaa92FzFfb7oYsOsKVXrgOIVJzhk 19. Tooth Spots: Fluorosis vs. Hypoplasia, https://drive.google.com/open?id=1qdmFDd5Hm12V1P44hcpBLItlaTpGJ6j8auBMoI0Bn-M 20. Amelogenesis Imperfecta; Genes, Proteins, and Pathways – Frontiers, truy cập vào tháng 11 13, 2025, https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2017.00435/full 21. Analyses of MMP20 Missense Mutations in Two Families with Hypomaturation Amelogenesis Imperfecta – Frontiers, truy cập vào tháng 11 13, 2025, https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2017.00229/full 22. Amelogenesis imperfecta – MedlinePlus, truy cập vào tháng 11 13, 2025, https://medlineplus.gov/download/genetics/condition/amelogenesis-imperfecta.pdf 23. Amelogenesis imperfecta – Wikipedia, truy cập vào tháng 11 13, 2025, https://en.wikipedia.org/wiki/Amelogenesis_imperfecta 24. AMELX Mutations and Genotype–Phenotype Correlation in X-Linked Amelogenesis Imperfecta – PMC – PubMed Central, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11172428/ 25. truy cập vào tháng 11 13, 2025, https://www.orpha.net/en/disease/detail/88661#:~:text=The%20prevalence%20varies%20from%201,according%20to%20the%20populations%20studied.&text=The%20enamel%20may%20be%20hypoplastic,sensitive%20or%20prone%20to%20disintegration. 26. Amelogenesis imperfecta – Orphanet, truy cập vào tháng 11 13, 2025, https://www.orpha.net/en/disease/detail/88661 27. FAM83H Mutations in Families with Autosomal-Dominant Hypocalcified Amelogenesis Imperfecta – PMC – NIH, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC2427219/ 28. MMP20 Active-site Mutation in Hypomaturation Amelogenesis Imperfecta – PubMed Central, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC1850238/ 29. Phenotypic Variation in FAM83H-associated Amelogenesis Imperfecta – PMC – NIH, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC2754853/ 30. Amelogenesis Imperfecta NGS Panel – Fulgent Genetics, truy cập vào tháng 11 13, 2025, https://fulgentgenetics.com/Amelogenesis-Imperfecta 31. A novel FAM83H variant causes familial amelogenesis imperfecta with incomplete penetrance – PMC – PubMed Central, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9000937/ 32. Human and Mouse Enamel Phenotypes Resulting from Mutation or Altered Expression of AMEL, ENAM, MMP20 and KLK4, truy cập vào tháng 11 13, 2025, https://cdr.lib.unc.edu/downloads/2j62sb798 33. FAM83H and Autosomal Dominant Hypocalcified Amelogenesis Imperfecta – PMC – NIH, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7903844/ 34. Identification of a Novel FAM83H Mutation and Management of Hypocalcified Amelogenesis Imperfecta in Early Childhood – MDPI, truy cập vào tháng 11 13, 2025, https://www.mdpi.com/2227-9067/9/3/429 35. A Recurrent FAM83H Mutation in an Extended Colombian Family and Variable Craniofacial Phenotypes – MDPI, truy cập vào tháng 11 13, 2025, https://www.mdpi.com/2227-9067/9/3/362 36. Identification of a Novel FAM83H Mutation and Management of Hypocalcified Amelogenesis Imperfecta in Early Childhood – NIH, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8947619/ 37. FAM83H gene: MedlinePlus Genetics, truy cập vào tháng 11 13, 2025, https://medlineplus.gov/genetics/gene/fam83h/ 38. Identifying a Novel Causal FAM83H Variant for Autosomal Dominant Amelogenesis Imperfecta Using Exome‐Sequencing – PMC – NIH, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC12162354/ 39. The Enamel Phenotype in Homozygous Fam83h Truncation Mice – McGill University, truy cập vào tháng 11 13, 2025, https://www.mcgill.ca/anatomy/files/anatomy/2019wang_fang_fam83htruncation.pdf 40. AMELX Mutations and Genotype-Phenotype Correlation in X-Linked Amelogenesis Imperfecta – PubMed, truy cập vào tháng 11 13, 2025, https://pubmed.ncbi.nlm.nih.gov/38892321/ 41. Amelogenesis imperfecta phenotype-genotype correlations with two amelogenin gene mutations – PubMed, truy cập vào tháng 11 13, 2025, https://pubmed.ncbi.nlm.nih.gov/11922869/ 42. AMELX Mutations and Genotype–Phenotype Correlation in X-Linked Amelogenesis Imperfecta – MDPI, truy cập vào tháng 11 13, 2025, https://www.mdpi.com/1422-0067/25/11/6132 43. Phenotype of ENAM Mutations is Dosage-dependent – PMC – NIH, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC2708095/ 44. Novel ENAM mutation responsible for autosomal recessive amelogenesis imperfecta and localised enamel defects – PubMed, truy cập vào tháng 11 13, 2025, https://pubmed.ncbi.nlm.nih.gov/14684688/ 45. Amelogenesis Imperfecta Due to a Mutation of the Enamelin Gene: Clinical Case With Genotype-phenotype Correlations – PubMed Central, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC2842984/ 46. A novel ENAM mutation causes hypoplastic amelogenesis imperfecta, truy cập vào tháng 11 13, 2025, https://ss.bjmu.edu.cn/Sites/Uploaded/File/2023/03/086381388468411940283372849.pdf 47. Novel KLK4 Mutations Cause Hypomaturation Amelogenesis Imperfecta – PMC – NIH, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8878363/ 48. The Molecular Etiologies and Associated Phenotypes of Amelogenesis Imperfecta – NIH, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC1847600/ 49. FAM83H gene – MedlinePlus, truy cập vào tháng 11 13, 2025, https://medlineplus.gov/download/genetics/gene/fam83h.pdf 50. Amelogenesis imperfecta: Next-generation sequencing sheds light on Witkop's classification, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10205041/ 51. Jalili syndrome (Concept Id: C3495589) – NCBI, truy cập vào tháng 11 13, 2025, https://www.ncbi.nlm.nih.gov/medgen/501210 52. Jalili syndrome – Orphanet, truy cập vào tháng 11 13, 2025, https://www.orpha.net/en/disease/detail/1873 53. Jalili Syndrome: Cross-sectional and Longitudinal Features of Seven Patients With Cone-Rod Dystrophy and Amelogenesis Imperfecta – PubMed, truy cập vào tháng 11 13, 2025, https://pubmed.ncbi.nlm.nih.gov/29421294/ 54. Jalili syndrome – Wikipedia, truy cập vào tháng 11 13, 2025, https://en.wikipedia.org/wiki/Jalili_syndrome 55. Novel Deletion in the CNNM4 Gene in Siblings with Jalili Syndrome | International Journal of Ophthalmology and Clinical Research, truy cập vào tháng 11 13, 2025, http://clinmedjournals.org/articles/ijocr/international-journal-of-ophthalmology-and-clinical-research-ijocr-3-046.php?jid=ijocr 56. Association of Amelogenesis Imperfecta and Bartter's Syndrome – PMC – NIH, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC5590420/ 57. truy cập vào tháng 11 13, 2025, https://www.orpha.net/en/disease/detail/1031#:~:text=A%20extremely%20rare%2C%20genetic%20malformation,tooth%20eruption%2C%20and%20intrapulpal%20calcifications. 58. Enamel-renal syndrome – Orphanet, truy cập vào tháng 11 13, 2025, https://www.orpha.net/en/disease/detail/1031 59. Amelogenesis Imperfecta with Nephrocalcinosis: A Rare Association in Siblings – PMC, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC6721873/ 60. Amelogenesis imperfecta with bilateral nephrocalcinosis – BMJ Case Reports, truy cập vào tháng 11 13, 2025, https://casereports.bmj.com/content/2013/bcr-2013-009370 61. (PDF) Patient-reported outcome measures in individuals with amelogenesis imperfecta: a systematic review – ResearchGate, truy cập vào tháng 11 13, 2025, https://www.researchgate.net/publication/362305008_Patient-reported_outcome_measures_in_individuals_with_amelogenesis_imperfecta_a_systematic_review 62. Patient-reported outcome measures in individuals with amelogenesis imperfecta: a systematic review – PubMed, truy cập vào tháng 11 13, 2025, https://pubmed.ncbi.nlm.nih.gov/35896941/ 63. Oral health-related quality of life in Northland Māori children and adolescents with Polynesian amelogenesis imperfecta – NIH, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11797879/ 64. Oral health-related quality of life in Northland Māori children and adolescents with Polynesian amelogenesis imperfecta – Frontiers, truy cập vào tháng 11 13, 2025, https://www.frontiersin.org/journals/dental-medicine/articles/10.3389/fdmed.2024.1485419/full 65. The Psychosocial Impacts of Developmental Enamel Defects in Children and Young People, truy cập vào tháng 11 13, 2025, https://pocketdentistry.com/the-psychosocial-impacts-of-developmental-enamel-defects-in-children-and-young-people/ 66. Experiences of Being a Parent to a Child with Amelogenesis Imperfecta – PMC, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC6473584/ 67. The impact of amelogenesis imperfecta and support needs of adolescents with AI and their parents: an exploratory study – PubMed, truy cập vào tháng 11 13, 2025, https://pubmed.ncbi.nlm.nih.gov/24404886/ 68. Oral health-related quality of life before and after crown therapy in young patients with amelogenesis imperfecta – PubMed, truy cập vào tháng 11 13, 2025, https://pubmed.ncbi.nlm.nih.gov/26651486/ 69. Patient-reported outcome measure for children and young people with amelogenesis imperfecta – PubMed, truy cập vào tháng 11 13, 2025, https://pubmed.ncbi.nlm.nih.gov/34489543/ 70. Etiology, Classification, and Restorative Management of Amelogenesis Imperfecta Among Children and Young Adults: A Scoping Review – PubMed, truy cập vào tháng 11 13, 2025, https://pubmed.ncbi.nlm.nih.gov/38179349/ 71. Amelogenesis Imperfecta: Transitional Phase of Management, truy cập vào tháng 11 13, 2025, https://biomedres.us/fulltexts/BJSTR.MS.ID.004887.php 72. Management of Amelogenesis Imperfecta in Childhood: Two Case Reports – PMC – NIH, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8297319/ 73. Guideline on Dental Management of Heritable Dental Developmental Anomalies – AAPD, truy cập vào tháng 11 13, 2025, https://www.aapd.org/assets/1/7/G_OHCHeritable2.PDF 74. Rehabilitation of a patient with amelogenesis imperfecta and severe open bite: A multidisciplinary approach – PMC, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC6389472/ 75. Clinical findings and long-term managements of patients with amelogenesis imperfecta, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC4253114/ 76. Orthodontic management of amelogenesis imperfecta: A case report – PMC – NIH, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11322039/ 77. Outcome of Restorative Treatment in Young Patients with Amelogenesis Imperfecta. A cross-sectional, retrospective study. | Request PDF – ResearchGate, truy cập vào tháng 11 13, 2025, https://www.researchgate.net/publication/264643598_Outcome_of_Restorative_Treatment_in_Young_Patients_with_Amelogenesis_Imperfecta_A_cross-sectional_retrospective_study 78. Outcome of restorative treatment in young patients with amelogenesis imperfecta. a cross-sectional, retrospective study – PubMed, truy cập vào tháng 11 13, 2025, https://pubmed.ncbi.nlm.nih.gov/25107287/ 79. Treatment considerations for patient with Amelogenesis Imperfecta: a review – PMC – NIH, truy cập vào tháng 11 13, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC4890618/ 80. Adhesive Bond Strength to Amelogenesis Imperfecta-Affected Enamel | Request PDF, truy cập vào tháng 11 13, 2025, https://www.researchgate.net/publication/266772041_Adhesive_Bond_Strength_to_Amelogenesis_Imperfecta-Affected_Enamel 81. Full-mouth adhesive rehabilitation in a case of amelogenesis imperfecta: a 5-year follow-up case report, truy cập vào tháng 11 13, 2025, http://francescavailati.com/wp-content/uploads/2023/03/2015-spring-international-journal-esthetic-dentistry.pdf 82. Complete rehabilitation of compromised full dentitions with adhesively bonded all-ceramic single-tooth restorations: Long-term outcome in patients with and without amelogenesis imperfecta – PubMed, truy cập vào tháng 11 13, 2025, https://pubmed.ncbi.nlm.nih.gov/29275170/